Proxy Results (Form 8-K)

Item 5.07 Submission of Matters to a Vote of Security Holders

Acadia Healthcare Company, Inc. (the "Company") held its annual meeting of stockholders on May 6, 2026 (the "Annual Meeting"). The proposals considered at the Annual Meeting were voted on as follows:

1.  The individuals listed below were elected to serve as Class III directors until the Company's annual meeting of stockholders in 2029 or until their successors have been elected and take office. The voting results were as follows:

2. The Company's stockholders approved a second amendment to the Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan, by the following vote:

3.  The Company's stockholders approved, on a non-binding advisory basis, the compensation of the Company's Named Executive Officers (as defined in the Company's definitive proxy statement filed with the SEC on March 25, 2026), by the following vote:

4. The Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026, by the following vote:

Description of Business

Unless the context otherwise requires, all references herein to "Acadia," "the Company," "we," "us" or "our" mean Acadia Healthcare Company, Inc. and its consolidated subsidiaries. Acadia Healthcare Company, Inc. is a holding company whose direct and indirect subsidiaries own and operate acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers, residential treatment centers and facilities providing outpatient behavioral healthcare services to serve the behavioral healthcare and recovery needs of communities throughout the U.S. and Puerto Rico.